Increased Epithelial Cadherin Expression Among Japanese Intestinal-Type Gastric Cancers Compared with Specimens from American Patients of European Descent
The different patterns of gastric cancer in the Far East and West have evolved to the extent that it has been suggested that the disease in Japan is biologically less aggressive than in the West. We studied paraffin-embedded, formalin-fixed tissue blocks from Japanese patients and American patients
A comparison of ten serological tumor markers for the detection of gastric cancer.
Gastric cancer comprises only 2% of cancer cases in the United States but represents the most prevalent cancer in less developed countries and the fourth most prevalent cancer world wide. Early diagnosis and therapeutic intervention could radically reduce the number of deaths attributed to this
Association of Helicobactor pylori infection with gastric cancer
Background: Helicobacter pylori has generated public health interest since its identification in 1983. Past studies have suggested that the bacterium plays a role in the pathogenesis of gastric cancer. More recent studies support the conclusion that the association of H. pylori with gastric cancer
Gastric cancer: diagnosis and treatment options.
The overall incidence of gastric cancer in the United States has rapidly declined over the past 50 years. Gastric cancer is now the 13th most common cause of cancer mortality in the United States, with an estimated 12,100 deaths in 2003. (1) However, in developing countries, the incidence of
The clinical and pathological features of patients with gastric cancer in Turkey: A Turkish Oncology Group Study
ABSTRACT Although the incidence of gastric cancer has declined dramatically in western countries; it is, after the breast cancer in women and lung cancer in men, the second most common cancer in Turkey with a high mortality. Surgery is the mainstay in the management of gastric cancer, and
Gastric cancer mortality and nitrate levels in Wisconsin drinking water.
GASTRIC CANCER is the eighth leading cause of cancer mortality in the United States. In 1985, the morta ty rate for gastric cancer in the United States was 4.6 per 100 000. Currently, the 5-y survival rate of individuals with gastric cancer is approximately 161] In Wisconsin, gastric cancer is the
Outcome of Hepatic Resection for Metastatic Gastric Cancer
The role of hepatic resection for metastatic gastric cancer is less well defined due to the tendency of gastric cancer to widely metastasize. The purpose of this study is to examine the beneficial effect of hepatic resection in patients with metastatic gastric cancer. The clinicopathologic features
Asian gastric cancer patients at a Southern California comprehensive cancer center are diagnosed with less advanced disease and have superior stage-stratified survival
The 5-year overall survival after curative gastrectomy for gastric cancer is markedly different in the West from that in the Far East. Japanese surgeons feel that extended lymphadenectomy contributes to this superior survival, although survival differences may reflect improved staging or less
Metastatic breast cancer manifested as refractory anemia and gastric polyps.
ABSTRACT Gastric metastasis from breast cancer is uncommon and typically occurs in patients with disseminated disease. The vast majority of patients with gastric lesions have a known preexisting diagnosis of breast cancer. In contrast, we describe a case in which a minimal breast cancer was found
Extended lymphadenectomy for gastric cancer: Results in a teaching hospital / Discussion
Lymphadenectomy including second-echelon lymph nodes (D^sub 2^ resection) for gastric cancer has not been widely adopted partly as a result of a reported increase in operative morbidity and mortality. In the present study we examined the operative risk of D^sub 2^ resection in a public teaching
